CEFAKIND 500MG (Cefuroxime (500mg))
-15%

CEFAKIND 500MG (Cefuroxime (500mg))

Original price was: ₹451.90.Current price is: ₹385.60.

Placeholder

Original price was: ₹451.90.Current price is: ₹385.60.

Add to cart
Buy Now
Category: Tag:

CEFAKIND 500MG tablets contain Cefuroxime as the active ingredient, formulated at a strength of 500mg. This medication falls under the category of second-generation cephalosporin antibiotics, which are well-established for their efficacy against a wide range of bacterial infections. The mechanism of action involves the disruption of bacterial cell wall synthesis, leading to the destruction of the bacteria that cause the infection. It is important to remember that CEFAKIND is specifically intended for the treatment of bacterial infections and should not be used against viral infections, including the common cold and influenza. The active ingredient, Cefuroxime, targets essential proteins within bacterial cells that are crucial for maintaining their cell wall structure. By binding to these proteins, Cefuroxime inhibits the bacteria’s ability to properly build and repair their cell walls. This bactericidal action ultimately leads to the lysis or death of the bacterial cells. CEFAKIND is indicated for various types of bacterial infections, including those affecting the respiratory tract, urinary system, ears, skin, and in certain cases, even for prophylaxis in surgical procedures. Patients are advised to follow the prescribed dosage and regimen to ensure the most effective results while minimizing the risk of side effects or complications. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.

Reviews

There are no reviews yet.

Be the first to review “CEFAKIND 500MG (Cefuroxime (500mg))”

Your email address will not be published. Required fields are marked *

Top